Valuation: Sysmex Corporation

Market Cap 1,000B 6.31B 5.48B 5.13B 4.69B 8.86B 602B 8.98B 60.03B 23.56B 301B 23.71B 23.19B P/E 2027 *
25.1x
P/E 2028 * 20.6x
Enterprise Value 1,019B 6.43B 5.58B 5.23B 4.78B 9.03B 613B 9.14B 61.15B 24B 306B 24.15B 23.63B EV / Sales 2027 *
1.9x
EV / Sales 2028 * 1.8x
Free-Float
72.3%
Yield 2027 *
2.34%
Yield 2028 * 2.44%
1 day+7.77%
1 week+7.77%
Current month+7.77%
1 month+17.51%
3 months+23.31%
6 months+5.32%
Current year+5.32%
1 week 10.4
Extreme 10.4
10.4
1 month 9.65
Extreme 9.65
10.4
Current year 7.97
Extreme 7.97
10.4
1 year 7.97
Extreme 7.97
13.92
3 years 7.97
Extreme 7.97
21.01
5 years 7.97
Extreme 7.97
45.45
10 years 7.97
Extreme 7.97
45.45
Manager TitleAgeSince
Chief Executive Officer 76 01/04/2018
Director of Finance/CFO 56 -
President 65 01/04/2026
Director TitleAgeSince
Chairman 76 01/04/2013
Director/Board Member 65 01/06/2019
Director/Board Member 71 01/06/2019
Change 5-day change 1-year change 3-year change Capi.($)
+7.77%+7.77% - - 6.27B
-0.72%+1.31%-18.92%-1.26% 187B
+0.25%+0.90%-5.57%+1.70% 110B
-0.51%+3.81%+16.10%+73.23% 62.02B
+0.65%+7.55%+37.26%+57.59% 53.79B
-1.00%+5.94%-6.51%-36.25% 48.79B
+0.66%+0.13%+9.37%-30.93% 31.33B
+3.23%-10.25% - - 30.27B
+1.76%+3.96%+47.36%-6.40% 24.53B
+1.21%+2.59%-0.81%+3.59% 22.59B
Average +1.32%+2.42%+9.78%+7.66% 63.35B
Weighted average by Cap. +0.15%+2.55%-0.04%+8.85%

Financials

2027 *2028 *
Net sales 536B 3.39B 2.94B 2.75B 2.52B 4.75B 323B 4.81B 32.2B 12.63B 161B 12.72B 12.44B 566B 3.57B 3.1B 2.9B 2.66B 5.01B 340B 5.08B 33.96B 13.33B 170B 13.41B 13.12B
Net income 40.28B 254M 221M 207M 189M 357M 24.22B 362M 2.42B 949M 12.1B 955M 934M 49.11B 310M 269M 252M 230M 435M 29.53B 441M 2.95B 1.16B 14.76B 1.16B 1.14B
Net Debt 18.61B 117M 102M 95.46M 87.32M 165M 11.19B 167M 1.12B 438M 5.59B 441M 431M 18.81B 119M 103M 96.51M 88.28M 167M 11.31B 169M 1.13B 443M 5.65B 446M 436M
Logo Sysmex Corporation
Sysmex Corp is a Japan-based company principally engaged in the health care business. The Company conducts product development, manufacturing, sales, and service in domestic markets, and some products are developed, manufactured, and sold by subsidiaries. Overseas, the Company conducts the manufacturing and sales of products in the Americas, EMEA, China, and Asia Pacific through other companies. Along with its subsidiaries, the Company is involved in the development, manufacture, sale and service of clinical laboratory equipment, laboratory test drugs and products related to laboratory test.
Employees
10,861
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
1,651.50JPY
Average target price
1,774.29JPY
Spread / Average Target
+7.43%

Quarterly revenue - Rate of surprise